The xCures technology platform uses artificial intelligence (A.I.) and predictive modeling to identify and rank the most promising treatment options for advanced cancer patients who are not responding to standard of care therapies.
Patients pay with their data. They sign a HIPAA release giving xCures the right to request their medical records. The platform then provides these patients a personalized list of top treatment options and information about how to access them.
The xCures platform captures Real World Evidence (RWE) from patients being treated in clinical trials, compassionate use and managed access programs, virtual and decentralized studies, investigator-initiated studies, and even N-of-1 clinical studies.
The RWE is used to accelerate the development of new drugs, expand the approved uses of existing drugs, and demonstrate value for reimbursement. The platform accepts records from any US-based institution, in any form, and compiles the data into a pan-cancer registry under an IRB-approved master protocol suitable for FDA submissions and medical publications.
xCures makes it possible to learn from the experiences of all patients who give us their data in return for treatment options, and optimize options selection for future patients.
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $12.7M
Founded date: 2018
Investors 5
Date | Name | Website |
- | Vanedge Ca... | vanedgecap... |
- | HealthTech... | healthtech... |
- | Wavemaker ... | wavemaker3... |
11.01.2022 | Civilizati... | civilizati... |
- | Unbridled ... | unbridled.... |
Funding Rounds 1
Date | Series | Amount | Investors |
23.06.2021 | Series A | $12.7M | - |
Mentions in press and media 22
Date | Title | Description | Source |
01.02.2024 | xCures Expands AI Health Data Platform: Now Supporting All T... | The company’s platform expansion transforms the value of US healthcare data by harnessing real-time,... | aithority.... |
06.12.2023 | xCures to offer clinical data extraction as a service in AWS... | AWS cloud configurations help xCures customers leverage the company’s data gathering and structuring... | einpresswi... |
06.06.2023 | CureMatch and xCures Partner to Revolutionize the Standard f... | CureMatch will leverage xCures technology that automatically creates a comprehensive outline of a pa... | einpresswi... |
26.05.2023 | xCures showcases the Power of its Real-time Clinical data pl... | Real-world patient data gives valuable insights, such as collecting data on rare cancers and showing... | einpresswi... |
20.12.2022 | xCures partners with RenovoRx to assist patients in accessin... | RenovoRx's Phase III clinical study is open to pancreatic adenocarcinoma patients and focuses on ext... | einpresswi... |
15.11.2022 | xCures presents clinical and translational research with two... | XCELSIOR registry showcases its power in using real-world datasets and clinical outcomes to aid deci... | einpresswi... |
25.08.2022 | xCures and Oblato announce the launch of a Compassionate Use... | Oblato’s first-in-class small molecular OKN-007 will be available through a newly opened compassiona... | einpresswi... |
24.08.2022 | Pancreatic Cancer Patients Will Now Have Remote Access to Pr... | xCures and Vault Health integration creates a decentralized platform to benefit pancreatic cancer re... | einpresswi... |
19.07.2022 | xCures partners with Travera to support advanced carcinoma p... | Decentralized clinical trial for patients with advanced carcinomas helps determine their cancer’s re... | einpresswi... |
21.06.2022 | xCures and Novocure® partner to better understand quality of... | Innovative collaboration focused on developing the first comprehensive Quality of Life dataset for g... | einpresswi... |
Show more